Dr. Asa Phichaphop

Asa Phichaphop, MD

Valve Science Center International Scholar

Dr. Asa Phichaphop is an interventional cardiologist, joining MHIF's Valve Science Center as an International Research Scholar. He received his medical degree and cardiology fellowship training from Chulalongkorn University in Bangkok, Thailand. After completing his training, he served as an attending physician in cardiology at Siriraj Hospital, Mahidol University in Thailand, where he helped found the Center of Excellence in Structural Heart Valve Intervention.

Throughout Dr. Phichaphop’s career, he has worked on over 1,000 coronary PCI cases and given over 20 scientific presentations at national and international conferences. He joined the Minneapolis Heart Institute Foundation team with an interest in structural heart intervention and functional valvular regurgitation therapy, bringing with him knowledge from over 100 TAVR cases. Dr. Phichaphop is excited to work with world-renowned leader of the Valve Science Center, Dr. Paul Sorajja.

Back to Valve Team Back to Current Scholars
 

Dr. Asa Phichaphop
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.